Emily L. Rapalino

Emily L. Rapalino

Partner
Emily L. Rapalino

Emily Rapalino, a partner in Goodwin’s IP Litigation Group, focuses her litigation practice on intellectual property, with an emphasis on patent litigation and opinion work, particularly in the areas of pharmaceuticals and biotechnology. Ms. Rapalino is the co-chair of the Boston council of Goodwin’s Womens’ Initiative and is the Litigation Hiring Partner in Boston.

Experience

Erfahrung

工作经历

Ms. Rapalino’s recent engagements include:

  • Lupin Limited in a patent infringement suit in District of New Jersey in connection with Prolensa, an ophthalmic anti-inflammatory drug.
  • Teva Pharmaceuticals USA, Inc.  in a patent infringement suit in District of Delaware in connection with a generic version of Genzyme’s stem cell mobilizing agent, Mozobil (plerixafor).
  • Cephalon Inc. in a patent infringement suit in District of Delaware in connection with Treanda, an anti-cancer drug.  After trial against five defendants, Cephalon prevailed in the district court on its claims of infringement against all defendants.
  • Fresenius Kabi USA LLC and Teva Parenteral Medicines Inc. in a patent infringement suit in the Southern District of Indiana in connection with Alimta, an anti-cancer drug.
  • Teva Pharmaceuticals in a patent infringement suit in District of New Jersey in connection with Prezista, an anti-HIV drug. Ms. Rapalino was involved in negotiating settlement of that case during trial.
  • Teva Pharmaceuticals in a patent infringement suit in connection with Lovenox, a blood thinning drug. Teva won summary judgment of non-infringement on two separate bases in Massachusetts District Court.
  • Teva Pharmaceuticals in a patent infringement suit in connection with Eloxatin, a colon cancer drug. After winning summary judgment of non-infringement in the New Jersey District Court, Teva prevailed in litigations in U.S. Court of Appeals for the Federal Circuit, the U.S. District Court for the District of Columbia and the U.S. Court of Appeals for the District of Columbia Circuit, clearing the way for the launch of its generic version of Eloxatin.
  • Supervision of pro bono Summer Associate Research Project for the Anti Defamation League
  • Pro bono representation of the Joyful Heart Foundation in connection with its end-the-rape-kit-backlog initiative
Professional Experience

Prior to joining Goodwin, Ms. Rapalino was an associate at Fish & Neave, where her practice concentrated on patent litigation, prosecution and counseling in the pharmaceutical, medical device and biotechnology fields.

Recognition

While attending law school, Ms. Rapalino was a member of the Columbia Law Review and a James Kent Scholar. Ms. Rapalino was named a Massachusetts Super Lawyers “Rising Star” in 2013.

In The News

In den Nachrichten

在新闻中

Credentials

Anmeldeinformationen

专业资格

Education

Bildung

教育背景

J.D., 2002
Columbia Law School
M.Sc., Life Sciences, 1999
Weizmann Institute of Science
A.B., Biology, 1996
Harvard University

(cum laude)

Admissions

Zulassung

律师资格

Bar

Bar

酒吧入场

Massachusetts
New York
New Jersey

Courts

Gerichte

法庭

U.S. District Court for the District of Massachusetts
U.S. District Court for the Southern District of New York
U.S. District Court for the Eastern District of New York
U.S. Court of Appeals for the Federal Circuit
Get In Touch
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.
Search Other Lawyers

Suche Andere Rechtsanwälte

搜寻其他律师